Anti-n-methyl-d-aspartate receptor (NMDAR) encephalitis: A series of ten cases from a university hospital in Malaysia

Neurology Asia

Volumn 16, Issue 3, 2011, Pages 241-246

  Abdullah, Suhailah ^a   Lim, Shen Yang ^a   Goh, Khean Jin ^a   Lum, Lucy C S ^a   Tan, Chong Tin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; CLONAZEPAM; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; ANTI N METHYL DEXTRO ASPARTIC ACID RECEPTOR ENCEPHALITIS; ARTICLE; AUDITORY HALLUCINATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HUMAN; INCIDENCE; MALAYSIA; MALE; MORTALITY; MOTOR DYSFUNCTION; OROFACIAL DYSKINESIA; OUTCOME ASSESSMENT; PLASMAPHERESIS; SCHOOL CHILD; SEIZURE; THYMECTOMY; UNIVERSITY HOSPITAL; VISUAL HALLUCINATION;

EID: 80053494322     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005; 58:594-604.
2. Dalmau J, Lauwster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10(1):63-74.
3. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36.
4. Irani SR, Bera K, Waters P, et al. N-Methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133:1655-67.
5. Florance NR, Davis RL, Lam C, et al. Anti-N-Methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66(1):11-8.
6. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10:759-72.
7. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231:86-91.
8. Davies G, Irani SR, Cordelia C, et al. Anti-N-methyl-D-aspartate receptor antibodies: A potentially treatable cause of encephalitis in the intensive care unit. Critical Care Med 2010; 38(2):679-82.
9. Granerod J, Ambrose HE, Davies NWS, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective Study. Lancet Infect Dis 2010; 10:835-44.
10. Kamei S, Kuzuhara S, Ishihara M, et al. Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-D-aspartate receptor encephalitis. Internal Med 2009; 48:673-9.
11. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:1421-9.